Molecular insights in potentiation of antibiotic activity by apple cider vinegar in diabetic wound pathogens Article Swipe
Syeda Mahanoor
,
Mohsin Ahmad Ghauri
,
Shakeel Ahmad
,
Rabia Mahmood
,
Muhammad Aqib Shabbir
,
Muhammad Adil Rasheed
,
Muhammad Ovais Omer
·
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s43094-025-00876-6
YOU?
·
· 2025
· Open Access
·
· DOI: https://doi.org/10.1186/s43094-025-00876-6
Background The prevalence of antibiotic resistance has become a critical global health concern. In particular, resistant strains of S taphylococcus aureus (SA) and Pseudomonas aeruginosa (PA) against commonly prescribed antibiotics for various infections are on the rise . These pathogens are frequently implicated in severe and complex infections, e.g., diabetic foot infections (DFI), posing a significant antimicrobial challenges during treatment. Frequently used food grade product, i.e., apple cider vinegar (ACV) carries promising antimicrobial potential. Therefore, the study designed to investigate the potential of ACV in combination with antibiotics to determine the effectiveness of the combination in overall pathogenic burden. Results Antimicrobial sensitivity was evaluated using disk diffusion and broth dilution techniques, revealing that at 2.5% acidity, ACV has prominent inhibitory potential against SA and PA . The fractional inhibitory concentration (FIC) index further confirmed synergistic interplay of ACV in combination with antibiotics. The results for minimum bactericidal concentration (MBC) showed when ACV is added to existing antibiotics the MBC value after checkerboard analysis method comes out to be, 128 µg/mL, 128 µg/mL, 64 µg/mL, and 64 µg/mL for amoxicillin, cefotaxime, imipenem, and vancomycin, respectively, against SA whereas concentration of 128 µg/mL, 256 µg/mL, 256 µg/mL, and 128 µg/mL MBC values for respective antibiotics against PA . Quantitative PCR analysis has demonstrated a substantial reduction in the expression of resistance-conferring genes when ACV was combined with antibiotics. Furthermore, molecular docking analysis showed ACV’s active constituents, such as acetic acid and chlorogenic acid, exhibited strong binding affinities against resistant conferring genes and subsequent proteins expression. These findings suggest that ACV may alter permeability of the outer membrane porin channels, thereby improving antibiotic penetration and augmented antimicrobial efficacy. Conclusion The study demonstrated that ACV not only improves antibiotic permeability within bacterial cell but also significantly augments bactericidal activity of these agents against resistant strains of SA and PA . The combination of various concentrations of ACV with antibiotics presents an innovative therapeutic strategy to combat current antimicrobial resistance, particularly in the treatment and management of complex DFI. These findings underscore the potential of integrating food grade products with conventional antibiotics to address the growing challenges of antibiotic resistance.
Related Topics
Concepts
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1186/s43094-025-00876-6
- https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6
- OA Status
- diamond
- References
- 41
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4413959900
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4413959900Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1186/s43094-025-00876-6Digital Object Identifier
- Title
-
Molecular insights in potentiation of antibiotic activity by apple cider vinegar in diabetic wound pathogensWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2025Year of publication
- Publication date
-
2025-09-03Full publication date if available
- Authors
-
Syeda Mahanoor, Mohsin Ahmad Ghauri, Shakeel Ahmad, Rabia Mahmood, Muhammad Aqib Shabbir, Muhammad Adil Rasheed, Muhammad Ovais OmerList of authors in order
- Landing page
-
https://doi.org/10.1186/s43094-025-00876-6Publisher landing page
- PDF URL
-
https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
diamondOpen access status per OpenAlex
- OA URL
-
https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6Direct OA link when available
- Concepts
-
Long-term potentiation, Antibiotics, Chemistry, Food science, Biotechnology, Traditional medicine, Biology, Medicine, Microbiology, Biochemistry, ReceptorTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- References (count)
-
41Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4413959900 |
|---|---|
| doi | https://doi.org/10.1186/s43094-025-00876-6 |
| ids.doi | https://doi.org/10.1186/s43094-025-00876-6 |
| ids.openalex | https://openalex.org/W4413959900 |
| fwci | 0.0 |
| type | article |
| title | Molecular insights in potentiation of antibiotic activity by apple cider vinegar in diabetic wound pathogens |
| biblio.issue | 1 |
| biblio.volume | 11 |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T10225 |
| topics[0].field.id | https://openalex.org/fields/11 |
| topics[0].field.display_name | Agricultural and Biological Sciences |
| topics[0].score | 0.9927999973297119 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1106 |
| topics[0].subfield.display_name | Food Science |
| topics[0].display_name | Essential Oils and Antimicrobial Activity |
| topics[1].id | https://openalex.org/T11386 |
| topics[1].field.id | https://openalex.org/fields/11 |
| topics[1].field.display_name | Agricultural and Biological Sciences |
| topics[1].score | 0.9865999817848206 |
| topics[1].domain.id | https://openalex.org/domains/1 |
| topics[1].domain.display_name | Life Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/1109 |
| topics[1].subfield.display_name | Insect Science |
| topics[1].display_name | Bee Products Chemical Analysis |
| topics[2].id | https://openalex.org/T10035 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9843000173568726 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2704 |
| topics[2].subfield.display_name | Biochemistry |
| topics[2].display_name | Phytochemicals and Antioxidant Activities |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C25274449 |
| concepts[0].level | 3 |
| concepts[0].score | 0.7990303635597229 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q1805481 |
| concepts[0].display_name | Long-term potentiation |
| concepts[1].id | https://openalex.org/C501593827 |
| concepts[1].level | 2 |
| concepts[1].score | 0.636211633682251 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q12187 |
| concepts[1].display_name | Antibiotics |
| concepts[2].id | https://openalex.org/C185592680 |
| concepts[2].level | 0 |
| concepts[2].score | 0.41039878129959106 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[2].display_name | Chemistry |
| concepts[3].id | https://openalex.org/C31903555 |
| concepts[3].level | 1 |
| concepts[3].score | 0.35679394006729126 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1637030 |
| concepts[3].display_name | Food science |
| concepts[4].id | https://openalex.org/C150903083 |
| concepts[4].level | 1 |
| concepts[4].score | 0.3329196572303772 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q7108 |
| concepts[4].display_name | Biotechnology |
| concepts[5].id | https://openalex.org/C556039675 |
| concepts[5].level | 1 |
| concepts[5].score | 0.33257877826690674 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q771035 |
| concepts[5].display_name | Traditional medicine |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.31493547558784485 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C71924100 |
| concepts[7].level | 0 |
| concepts[7].score | 0.3113117814064026 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[7].display_name | Medicine |
| concepts[8].id | https://openalex.org/C89423630 |
| concepts[8].level | 1 |
| concepts[8].score | 0.30867499113082886 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7193 |
| concepts[8].display_name | Microbiology |
| concepts[9].id | https://openalex.org/C55493867 |
| concepts[9].level | 1 |
| concepts[9].score | 0.19466561079025269 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7094 |
| concepts[9].display_name | Biochemistry |
| concepts[10].id | https://openalex.org/C170493617 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[10].display_name | Receptor |
| keywords[0].id | https://openalex.org/keywords/long-term-potentiation |
| keywords[0].score | 0.7990303635597229 |
| keywords[0].display_name | Long-term potentiation |
| keywords[1].id | https://openalex.org/keywords/antibiotics |
| keywords[1].score | 0.636211633682251 |
| keywords[1].display_name | Antibiotics |
| keywords[2].id | https://openalex.org/keywords/chemistry |
| keywords[2].score | 0.41039878129959106 |
| keywords[2].display_name | Chemistry |
| keywords[3].id | https://openalex.org/keywords/food-science |
| keywords[3].score | 0.35679394006729126 |
| keywords[3].display_name | Food science |
| keywords[4].id | https://openalex.org/keywords/biotechnology |
| keywords[4].score | 0.3329196572303772 |
| keywords[4].display_name | Biotechnology |
| keywords[5].id | https://openalex.org/keywords/traditional-medicine |
| keywords[5].score | 0.33257877826690674 |
| keywords[5].display_name | Traditional medicine |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.31493547558784485 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/medicine |
| keywords[7].score | 0.3113117814064026 |
| keywords[7].display_name | Medicine |
| keywords[8].id | https://openalex.org/keywords/microbiology |
| keywords[8].score | 0.30867499113082886 |
| keywords[8].display_name | Microbiology |
| keywords[9].id | https://openalex.org/keywords/biochemistry |
| keywords[9].score | 0.19466561079025269 |
| keywords[9].display_name | Biochemistry |
| language | en |
| locations[0].id | doi:10.1186/s43094-025-00876-6 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S2898388368 |
| locations[0].source.issn | 2314-7245, 2314-7253 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | True |
| locations[0].source.issn_l | 2314-7245 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | True |
| locations[0].source.display_name | Future Journal of Pharmaceutical Sciences |
| locations[0].source.host_organization | https://openalex.org/P4310319900 |
| locations[0].source.host_organization_name | Springer Science+Business Media |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310319900 |
| locations[0].license | cc-by |
| locations[0].pdf_url | https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Future Journal of Pharmaceutical Sciences |
| locations[0].landing_page_url | https://doi.org/10.1186/s43094-025-00876-6 |
| locations[1].id | pmh:oai:doaj.org/article:937c4e22672344e087dfd62286f520c0 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306401280 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | DOAJ (DOAJ: Directory of Open Access Journals) |
| locations[1].source.host_organization | |
| locations[1].source.host_organization_name | |
| locations[1].source.host_organization_lineage | |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | submittedVersion |
| locations[1].raw_type | article |
| locations[1].license_id | |
| locations[1].is_accepted | False |
| locations[1].is_published | False |
| locations[1].raw_source_name | Future Journal of Pharmaceutical Sciences, Vol 11, Iss 1, Pp 1-14 (2025) |
| locations[1].landing_page_url | https://doaj.org/article/937c4e22672344e087dfd62286f520c0 |
| indexed_in | crossref, doaj |
| authorships[0].author.id | https://openalex.org/A5119529803 |
| authorships[0].author.orcid | |
| authorships[0].author.display_name | Syeda Mahanoor |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Syeda Mahanoor |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5107084628 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-5367-8216 |
| authorships[1].author.display_name | Mohsin Ahmad Ghauri |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Mohsin Ahmad Ghauri |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5102009958 |
| authorships[2].author.orcid | https://orcid.org/0000-0003-2091-2835 |
| authorships[2].author.display_name | Shakeel Ahmad |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Shakeel Ahmad |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5048952669 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-7163-0577 |
| authorships[3].author.display_name | Rabia Mahmood |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Rabia Mahmood |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5012816807 |
| authorships[4].author.orcid | https://orcid.org/0000-0001-7912-3983 |
| authorships[4].author.display_name | Muhammad Aqib Shabbir |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Muhammad Aqib Shabbir |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5068506236 |
| authorships[5].author.orcid | https://orcid.org/0000-0002-5601-7560 |
| authorships[5].author.display_name | Muhammad Adil Rasheed |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Muhammad Adil Rasheed |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5004794264 |
| authorships[6].author.orcid | https://orcid.org/0000-0001-8860-0972 |
| authorships[6].author.display_name | Muhammad Ovais Omer |
| authorships[6].author_position | last |
| authorships[6].raw_author_name | Muhammad Ovais Omer |
| authorships[6].is_corresponding | False |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6 |
| open_access.oa_status | diamond |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Molecular insights in potentiation of antibiotic activity by apple cider vinegar in diabetic wound pathogens |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T10225 |
| primary_topic.field.id | https://openalex.org/fields/11 |
| primary_topic.field.display_name | Agricultural and Biological Sciences |
| primary_topic.score | 0.9927999973297119 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1106 |
| primary_topic.subfield.display_name | Food Science |
| primary_topic.display_name | Essential Oils and Antimicrobial Activity |
| related_works | https://openalex.org/W2021919621, https://openalex.org/W2930273092, https://openalex.org/W3104201724, https://openalex.org/W2077664665, https://openalex.org/W2135488678, https://openalex.org/W2323553249, https://openalex.org/W2051473177, https://openalex.org/W2138310310, https://openalex.org/W2044845422, https://openalex.org/W1994188674 |
| cited_by_count | 0 |
| locations_count | 2 |
| best_oa_location.id | doi:10.1186/s43094-025-00876-6 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S2898388368 |
| best_oa_location.source.issn | 2314-7245, 2314-7253 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | True |
| best_oa_location.source.issn_l | 2314-7245 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | True |
| best_oa_location.source.display_name | Future Journal of Pharmaceutical Sciences |
| best_oa_location.source.host_organization | https://openalex.org/P4310319900 |
| best_oa_location.source.host_organization_name | Springer Science+Business Media |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Future Journal of Pharmaceutical Sciences |
| best_oa_location.landing_page_url | https://doi.org/10.1186/s43094-025-00876-6 |
| primary_location.id | doi:10.1186/s43094-025-00876-6 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S2898388368 |
| primary_location.source.issn | 2314-7245, 2314-7253 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | True |
| primary_location.source.issn_l | 2314-7245 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | True |
| primary_location.source.display_name | Future Journal of Pharmaceutical Sciences |
| primary_location.source.host_organization | https://openalex.org/P4310319900 |
| primary_location.source.host_organization_name | Springer Science+Business Media |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310319900 |
| primary_location.license | cc-by |
| primary_location.pdf_url | https://fjps.springeropen.com/counter/pdf/10.1186/s43094-025-00876-6 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Future Journal of Pharmaceutical Sciences |
| primary_location.landing_page_url | https://doi.org/10.1186/s43094-025-00876-6 |
| publication_date | 2025-09-03 |
| publication_year | 2025 |
| referenced_works | https://openalex.org/W3194188670, https://openalex.org/W2765346922, https://openalex.org/W2901667615, https://openalex.org/W2342937250, https://openalex.org/W2811512821, https://openalex.org/W2755440815, https://openalex.org/W2274251352, https://openalex.org/W3080460032, https://openalex.org/W2603755876, https://openalex.org/W3157884104, https://openalex.org/W2535665921, https://openalex.org/W3199469962, https://openalex.org/W2434692906, https://openalex.org/W3119628799, https://openalex.org/W2797357126, https://openalex.org/W2589262588, https://openalex.org/W2525225058, https://openalex.org/W2339844999, https://openalex.org/W3216273285, https://openalex.org/W3128852314, https://openalex.org/W2745942773, https://openalex.org/W2624518398, https://openalex.org/W4383998229, https://openalex.org/W2805723528, https://openalex.org/W2546858755, https://openalex.org/W4289521685, https://openalex.org/W4206662055, https://openalex.org/W4324146064, https://openalex.org/W3176017627, https://openalex.org/W4309666648, https://openalex.org/W3210890336, https://openalex.org/W4405986977, https://openalex.org/W4390350180, https://openalex.org/W4393257142, https://openalex.org/W3126183343, https://openalex.org/W2097681244, https://openalex.org/W4289779354, https://openalex.org/W4308785559, https://openalex.org/W4386880231, https://openalex.org/W4390084235, https://openalex.org/W4399057049 |
| referenced_works_count | 41 |
| abstract_inverted_index.. | 38, 126, 206, 306 |
| abstract_inverted_index.S | 19 |
| abstract_inverted_index.a | 9, 55, 212 |
| abstract_inverted_index.64 | 173, 176 |
| abstract_inverted_index.In | 14 |
| abstract_inverted_index.PA | 125, 205, 305 |
| abstract_inverted_index.SA | 123, 186, 303 |
| abstract_inverted_index.an | 317 |
| abstract_inverted_index.as | 236 |
| abstract_inverted_index.at | 114 |
| abstract_inverted_index.in | 44, 85, 96, 139, 215, 327 |
| abstract_inverted_index.is | 153 |
| abstract_inverted_index.of | 4, 18, 83, 93, 137, 189, 218, 262, 296, 302, 309, 312, 332, 340, 353 |
| abstract_inverted_index.on | 35 |
| abstract_inverted_index.to | 79, 89, 155, 167, 321, 348 |
| abstract_inverted_index.128 | 169, 171, 190, 197 |
| abstract_inverted_index.256 | 192, 194 |
| abstract_inverted_index.ACV | 84, 117, 138, 152, 222, 258, 281, 313 |
| abstract_inverted_index.MBC | 159, 199 |
| abstract_inverted_index.PCR | 208 |
| abstract_inverted_index.The | 2, 127, 143, 277, 307 |
| abstract_inverted_index.and | 23, 46, 108, 124, 175, 182, 196, 239, 250, 272, 304, 330 |
| abstract_inverted_index.are | 34, 41 |
| abstract_inverted_index.be, | 168 |
| abstract_inverted_index.but | 290 |
| abstract_inverted_index.for | 31, 145, 178, 201 |
| abstract_inverted_index.has | 7, 118, 210 |
| abstract_inverted_index.may | 259 |
| abstract_inverted_index.not | 282 |
| abstract_inverted_index.out | 166 |
| abstract_inverted_index.the | 36, 76, 81, 91, 94, 158, 216, 263, 328, 338, 350 |
| abstract_inverted_index.was | 103, 223 |
| abstract_inverted_index.(PA) | 26 |
| abstract_inverted_index.(SA) | 22 |
| abstract_inverted_index.2.5% | 115 |
| abstract_inverted_index.DFI. | 334 |
| abstract_inverted_index.acid | 238 |
| abstract_inverted_index.also | 291 |
| abstract_inverted_index.cell | 289 |
| abstract_inverted_index.disk | 106 |
| abstract_inverted_index.food | 63, 342 |
| abstract_inverted_index.foot | 51 |
| abstract_inverted_index.only | 283 |
| abstract_inverted_index.rise | 37 |
| abstract_inverted_index.such | 235 |
| abstract_inverted_index.that | 113, 257, 280 |
| abstract_inverted_index.used | 62 |
| abstract_inverted_index.when | 151, 221 |
| abstract_inverted_index.with | 87, 141, 225, 314, 345 |
| abstract_inverted_index.(ACV) | 70 |
| abstract_inverted_index.(FIC) | 131 |
| abstract_inverted_index.(MBC) | 149 |
| abstract_inverted_index.These | 39, 254, 335 |
| abstract_inverted_index.acid, | 241 |
| abstract_inverted_index.added | 154 |
| abstract_inverted_index.after | 161 |
| abstract_inverted_index.alter | 260 |
| abstract_inverted_index.apple | 67 |
| abstract_inverted_index.broth | 109 |
| abstract_inverted_index.cider | 68 |
| abstract_inverted_index.comes | 165 |
| abstract_inverted_index.e.g., | 49 |
| abstract_inverted_index.genes | 220, 249 |
| abstract_inverted_index.grade | 64, 343 |
| abstract_inverted_index.i.e., | 66 |
| abstract_inverted_index.index | 132 |
| abstract_inverted_index.outer | 264 |
| abstract_inverted_index.porin | 266 |
| abstract_inverted_index.study | 77, 278 |
| abstract_inverted_index.these | 297 |
| abstract_inverted_index.using | 105 |
| abstract_inverted_index.value | 160 |
| abstract_inverted_index.(DFI), | 53 |
| abstract_inverted_index.acetic | 237 |
| abstract_inverted_index.active | 233 |
| abstract_inverted_index.agents | 298 |
| abstract_inverted_index.aureus | 21 |
| abstract_inverted_index.become | 8 |
| abstract_inverted_index.combat | 322 |
| abstract_inverted_index.during | 59 |
| abstract_inverted_index.global | 11 |
| abstract_inverted_index.health | 12 |
| abstract_inverted_index.method | 164 |
| abstract_inverted_index.posing | 54 |
| abstract_inverted_index.severe | 45 |
| abstract_inverted_index.showed | 150, 231 |
| abstract_inverted_index.strong | 243 |
| abstract_inverted_index.values | 200 |
| abstract_inverted_index.within | 287 |
| abstract_inverted_index.µg/mL | 177, 198 |
| abstract_inverted_index.ACV’s | 232 |
| abstract_inverted_index.Results | 100 |
| abstract_inverted_index.address | 349 |
| abstract_inverted_index.against | 27, 122, 185, 204, 246, 299 |
| abstract_inverted_index.binding | 244 |
| abstract_inverted_index.burden. | 99 |
| abstract_inverted_index.carries | 71 |
| abstract_inverted_index.complex | 47, 333 |
| abstract_inverted_index.current | 323 |
| abstract_inverted_index.docking | 229 |
| abstract_inverted_index.further | 133 |
| abstract_inverted_index.growing | 351 |
| abstract_inverted_index.minimum | 146 |
| abstract_inverted_index.overall | 97 |
| abstract_inverted_index.results | 144 |
| abstract_inverted_index.strains | 17, 301 |
| abstract_inverted_index.suggest | 256 |
| abstract_inverted_index.thereby | 268 |
| abstract_inverted_index.various | 32, 310 |
| abstract_inverted_index.vinegar | 69 |
| abstract_inverted_index.whereas | 187 |
| abstract_inverted_index.µg/mL, | 170, 172, 174, 191, 193, 195 |
| abstract_inverted_index.Abstract | 0 |
| abstract_inverted_index.acidity, | 116 |
| abstract_inverted_index.activity | 295 |
| abstract_inverted_index.analysis | 163, 209, 230 |
| abstract_inverted_index.augments | 293 |
| abstract_inverted_index.combined | 224 |
| abstract_inverted_index.commonly | 28 |
| abstract_inverted_index.concern. | 13 |
| abstract_inverted_index.critical | 10 |
| abstract_inverted_index.designed | 78 |
| abstract_inverted_index.diabetic | 50 |
| abstract_inverted_index.dilution | 110 |
| abstract_inverted_index.existing | 156 |
| abstract_inverted_index.findings | 255, 336 |
| abstract_inverted_index.improves | 284 |
| abstract_inverted_index.membrane | 265 |
| abstract_inverted_index.presents | 316 |
| abstract_inverted_index.product, | 65 |
| abstract_inverted_index.products | 344 |
| abstract_inverted_index.proteins | 252 |
| abstract_inverted_index.strategy | 320 |
| abstract_inverted_index.augmented | 273 |
| abstract_inverted_index.bacterial | 288 |
| abstract_inverted_index.channels, | 267 |
| abstract_inverted_index.confirmed | 134 |
| abstract_inverted_index.determine | 90 |
| abstract_inverted_index.diffusion | 107 |
| abstract_inverted_index.efficacy. | 275 |
| abstract_inverted_index.evaluated | 104 |
| abstract_inverted_index.exhibited | 242 |
| abstract_inverted_index.imipenem, | 181 |
| abstract_inverted_index.improving | 269 |
| abstract_inverted_index.interplay | 136 |
| abstract_inverted_index.molecular | 228 |
| abstract_inverted_index.pathogens | 40 |
| abstract_inverted_index.potential | 82, 121, 339 |
| abstract_inverted_index.prominent | 119 |
| abstract_inverted_index.promising | 72 |
| abstract_inverted_index.reduction | 214 |
| abstract_inverted_index.resistant | 16, 247, 300 |
| abstract_inverted_index.revealing | 112 |
| abstract_inverted_index.treatment | 329 |
| abstract_inverted_index.Background | 1 |
| abstract_inverted_index.Conclusion | 276 |
| abstract_inverted_index.Frequently | 61 |
| abstract_inverted_index.Therefore, | 75 |
| abstract_inverted_index.aeruginosa | 25 |
| abstract_inverted_index.affinities | 245 |
| abstract_inverted_index.antibiotic | 5, 270, 285, 354 |
| abstract_inverted_index.challenges | 58, 352 |
| abstract_inverted_index.conferring | 248 |
| abstract_inverted_index.expression | 217 |
| abstract_inverted_index.fractional | 128 |
| abstract_inverted_index.frequently | 42 |
| abstract_inverted_index.implicated | 43 |
| abstract_inverted_index.infections | 33, 52 |
| abstract_inverted_index.inhibitory | 120, 129 |
| abstract_inverted_index.innovative | 318 |
| abstract_inverted_index.management | 331 |
| abstract_inverted_index.pathogenic | 98 |
| abstract_inverted_index.potential. | 74 |
| abstract_inverted_index.prescribed | 29 |
| abstract_inverted_index.prevalence | 3 |
| abstract_inverted_index.resistance | 6 |
| abstract_inverted_index.respective | 202 |
| abstract_inverted_index.subsequent | 251 |
| abstract_inverted_index.treatment. | 60 |
| abstract_inverted_index.underscore | 337 |
| abstract_inverted_index.Pseudomonas | 24 |
| abstract_inverted_index.antibiotics | 30, 88, 157, 203, 315, 347 |
| abstract_inverted_index.cefotaxime, | 180 |
| abstract_inverted_index.chlorogenic | 240 |
| abstract_inverted_index.combination | 86, 95, 140, 308 |
| abstract_inverted_index.expression. | 253 |
| abstract_inverted_index.infections, | 48 |
| abstract_inverted_index.integrating | 341 |
| abstract_inverted_index.investigate | 80 |
| abstract_inverted_index.particular, | 15 |
| abstract_inverted_index.penetration | 271 |
| abstract_inverted_index.resistance, | 325 |
| abstract_inverted_index.resistance. | 355 |
| abstract_inverted_index.sensitivity | 102 |
| abstract_inverted_index.significant | 56 |
| abstract_inverted_index.substantial | 213 |
| abstract_inverted_index.synergistic | 135 |
| abstract_inverted_index.techniques, | 111 |
| abstract_inverted_index.therapeutic | 319 |
| abstract_inverted_index.vancomycin, | 183 |
| abstract_inverted_index.Furthermore, | 227 |
| abstract_inverted_index.Quantitative | 207 |
| abstract_inverted_index.amoxicillin, | 179 |
| abstract_inverted_index.antibiotics. | 142, 226 |
| abstract_inverted_index.bactericidal | 147, 294 |
| abstract_inverted_index.checkerboard | 162 |
| abstract_inverted_index.conventional | 346 |
| abstract_inverted_index.demonstrated | 211, 279 |
| abstract_inverted_index.particularly | 326 |
| abstract_inverted_index.permeability | 261, 286 |
| abstract_inverted_index.Antimicrobial | 101 |
| abstract_inverted_index.antimicrobial | 57, 73, 274, 324 |
| abstract_inverted_index.concentration | 130, 148, 188 |
| abstract_inverted_index.constituents, | 234 |
| abstract_inverted_index.effectiveness | 92 |
| abstract_inverted_index.respectively, | 184 |
| abstract_inverted_index.significantly | 292 |
| abstract_inverted_index.taphylococcus | 20 |
| abstract_inverted_index.concentrations | 311 |
| abstract_inverted_index.resistance-conferring | 219 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 7 |
| citation_normalized_percentile.value | 0.47948896 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |